ECL
ECL
Ecolab Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $4.07B ▼ | $1.15B ▲ | $432.6M ▼ | 10.64% ▼ | $1.53 ▼ | $613.2M ▼ |
| Q4-2025 | $4.2B ▲ | $1.06B ▼ | $563.9M ▼ | 13.44% ▼ | $2 ▼ | $903.4M ▲ |
| Q3-2025 | $4.17B ▲ | $1.11B ▲ | $585M ▲ | 14.05% ▲ | $2.06 ▲ | $789M ▼ |
| Q2-2025 | $4.03B ▲ | $1.09B ▲ | $524.2M ▲ | 13.02% ▲ | $1.85 ▲ | $977.8M ▲ |
| Q1-2025 | $3.69B | $1.05B | $402.5M | 10.89% | $1.42 | $818.2M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $519.8M ▼ | $25.04B ▲ | $15.01B ▲ | $10B ▲ |
| Q4-2025 | $646.2M ▼ | $24.7B ▲ | $14.89B ▲ | $9.77B ▲ |
| Q3-2025 | $1.96B ▲ | $23.9B ▲ | $14.14B ▼ | $9.72B ▲ |
| Q2-2025 | $1.92B ▲ | $23.74B ▲ | $14.39B ▲ | $9.32B ▲ |
| Q1-2025 | $1.16B | $22.37B | $13.46B | $8.88B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $436.6M ▼ | $445.9M ▼ | $-355.5M ▲ | $-225.8M ▲ | $-126.4M ▲ | $97.4M ▼ |
| Q4-2025 | $568.6M ▼ | $1.09B ▲ | $-1.98B ▼ | $-431.6M ▲ | $-1.31B ▼ | $758M ▲ |
| Q3-2025 | $589.7M ▲ | $791.3M ▲ | $-280.6M ▼ | $-477.4M ▼ | $34.9M ▼ | $529.7M ▲ |
| Q2-2025 | $528.5M ▲ | $701.8M ▲ | $-224.4M ▼ | $297.3M ▲ | $758.3M ▲ | $485.1M ▲ |
| Q1-2025 | $406.5M | $369.4M | $-224M | $-241.6M | $-94.2M | $131.5M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Global Institutional and Specialty | $1.54Bn ▲ | $1.59Bn ▲ | $1.55Bn ▼ | $1.51Bn ▼ |
Global Life Sciences | $190.00M ▲ | $180.00M ▼ | $210.00M ▲ | $200.00M ▼ |
Global Pest Elimination | $320.00M ▲ | $330.00M ▲ | $320.00M ▼ | $310.00M ▼ |
Global Water | $1.98Bn ▲ | $2.05Bn ▲ | $2.12Bn ▲ | $2.04Bn ▼ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Asia Pacific | $330.00M ▲ | $340.00M ▲ | $380.00M ▲ | $350.00M ▼ |
C N | $180.00M ▲ | $180.00M ▲ | $180.00M ▲ | $230.00M ▲ |
CANADA | $120.00M ▲ | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ |
Europe | $810.00M ▲ | $860.00M ▲ | $890.00M ▲ | $810.00M ▼ |
Latin America | $260.00M ▲ | $280.00M ▲ | $310.00M ▲ | $270.00M ▼ |
Middle East And Africa | $160.00M ▲ | $160.00M ▲ | $190.00M ▲ | $140.00M ▼ |
UNITED STATES | $2.15Bn ▲ | $2.21Bn ▲ | $2.12Bn ▼ | $2.13Bn ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Ecolab Inc.'s financial evolution and strategic trajectory over the past five years.
Ecolab combines steady, broad-based revenue growth with improving profitability and strong cash generation. Its business model blends consumables, equipment, digital tools, and on-site service into a highly sticky offering with high switching costs. The company has a leading global position in essential areas such as water management, hygiene, and infection prevention, and it is building strong platforms in life sciences, microelectronics, and data centers. The balance sheet benefits from growing retained earnings and equity, and the cash flow statement shows an ability to fund substantial growth investments while consistently returning capital to shareholders.
Key risks center on financial leverage, liquidity, and execution. Net debt has risen recently and cash balances have fallen, while short-term obligations have grown faster than liquid assets, tightening the liquidity profile. EBITDA volatility and a slight dip in net income in the latest year hint at susceptibility to non-operating factors or one-off shocks. Heavy use of acquisitions and the buildup of goodwill create integration risk and potential for future write-downs if deals underperform. The apparent elimination of reported R&D spending, despite an innovation-heavy strategy, raises questions about the sustainability and transparency of internal development efforts. Finally, exposure to cyclical and regulated industries means that macroeconomic downturns and regulatory shifts can meaningfully affect demand and costs.
Taken together, Ecolab appears positioned for continued long-term growth, supported by structural demand for cleaner, safer, and more resource-efficient operations across many industries. Its strong competitive moat, digital and sustainability focus, and presence in high-growth sectors provide a solid foundation. However, the more aggressive capital deployment of recent years—through higher capex, acquisitions, and large buybacks—combined with weaker liquidity and higher net debt, increases the importance of disciplined execution and careful risk management. Future results will likely hinge on the company’s ability to translate its innovation pipeline and strategic acquisitions into sustained margin expansion and robust cash flows while gradually rebuilding financial flexibility.
About Ecolab Inc.
https://www.ecolab.comEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $4.07B ▼ | $1.15B ▲ | $432.6M ▼ | 10.64% ▼ | $1.53 ▼ | $613.2M ▼ |
| Q4-2025 | $4.2B ▲ | $1.06B ▼ | $563.9M ▼ | 13.44% ▼ | $2 ▼ | $903.4M ▲ |
| Q3-2025 | $4.17B ▲ | $1.11B ▲ | $585M ▲ | 14.05% ▲ | $2.06 ▲ | $789M ▼ |
| Q2-2025 | $4.03B ▲ | $1.09B ▲ | $524.2M ▲ | 13.02% ▲ | $1.85 ▲ | $977.8M ▲ |
| Q1-2025 | $3.69B | $1.05B | $402.5M | 10.89% | $1.42 | $818.2M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $519.8M ▼ | $25.04B ▲ | $15.01B ▲ | $10B ▲ |
| Q4-2025 | $646.2M ▼ | $24.7B ▲ | $14.89B ▲ | $9.77B ▲ |
| Q3-2025 | $1.96B ▲ | $23.9B ▲ | $14.14B ▼ | $9.72B ▲ |
| Q2-2025 | $1.92B ▲ | $23.74B ▲ | $14.39B ▲ | $9.32B ▲ |
| Q1-2025 | $1.16B | $22.37B | $13.46B | $8.88B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $436.6M ▼ | $445.9M ▼ | $-355.5M ▲ | $-225.8M ▲ | $-126.4M ▲ | $97.4M ▼ |
| Q4-2025 | $568.6M ▼ | $1.09B ▲ | $-1.98B ▼ | $-431.6M ▲ | $-1.31B ▼ | $758M ▲ |
| Q3-2025 | $589.7M ▲ | $791.3M ▲ | $-280.6M ▼ | $-477.4M ▼ | $34.9M ▼ | $529.7M ▲ |
| Q2-2025 | $528.5M ▲ | $701.8M ▲ | $-224.4M ▼ | $297.3M ▲ | $758.3M ▲ | $485.1M ▲ |
| Q1-2025 | $406.5M | $369.4M | $-224M | $-241.6M | $-94.2M | $131.5M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Global Institutional and Specialty | $1.54Bn ▲ | $1.59Bn ▲ | $1.55Bn ▼ | $1.51Bn ▼ |
Global Life Sciences | $190.00M ▲ | $180.00M ▼ | $210.00M ▲ | $200.00M ▼ |
Global Pest Elimination | $320.00M ▲ | $330.00M ▲ | $320.00M ▼ | $310.00M ▼ |
Global Water | $1.98Bn ▲ | $2.05Bn ▲ | $2.12Bn ▲ | $2.04Bn ▼ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Asia Pacific | $330.00M ▲ | $340.00M ▲ | $380.00M ▲ | $350.00M ▼ |
C N | $180.00M ▲ | $180.00M ▲ | $180.00M ▲ | $230.00M ▲ |
CANADA | $120.00M ▲ | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ |
Europe | $810.00M ▲ | $860.00M ▲ | $890.00M ▲ | $810.00M ▼ |
Latin America | $260.00M ▲ | $280.00M ▲ | $310.00M ▲ | $270.00M ▼ |
Middle East And Africa | $160.00M ▲ | $160.00M ▲ | $190.00M ▲ | $140.00M ▼ |
UNITED STATES | $2.15Bn ▲ | $2.21Bn ▲ | $2.12Bn ▼ | $2.13Bn ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Ecolab Inc.'s financial evolution and strategic trajectory over the past five years.
Ecolab combines steady, broad-based revenue growth with improving profitability and strong cash generation. Its business model blends consumables, equipment, digital tools, and on-site service into a highly sticky offering with high switching costs. The company has a leading global position in essential areas such as water management, hygiene, and infection prevention, and it is building strong platforms in life sciences, microelectronics, and data centers. The balance sheet benefits from growing retained earnings and equity, and the cash flow statement shows an ability to fund substantial growth investments while consistently returning capital to shareholders.
Key risks center on financial leverage, liquidity, and execution. Net debt has risen recently and cash balances have fallen, while short-term obligations have grown faster than liquid assets, tightening the liquidity profile. EBITDA volatility and a slight dip in net income in the latest year hint at susceptibility to non-operating factors or one-off shocks. Heavy use of acquisitions and the buildup of goodwill create integration risk and potential for future write-downs if deals underperform. The apparent elimination of reported R&D spending, despite an innovation-heavy strategy, raises questions about the sustainability and transparency of internal development efforts. Finally, exposure to cyclical and regulated industries means that macroeconomic downturns and regulatory shifts can meaningfully affect demand and costs.
Taken together, Ecolab appears positioned for continued long-term growth, supported by structural demand for cleaner, safer, and more resource-efficient operations across many industries. Its strong competitive moat, digital and sustainability focus, and presence in high-growth sectors provide a solid foundation. However, the more aggressive capital deployment of recent years—through higher capex, acquisitions, and large buybacks—combined with weaker liquidity and higher net debt, increases the importance of disciplined execution and careful risk management. Future results will likely hinge on the company’s ability to translate its innovation pipeline and strategic acquisitions into sustained margin expansion and robust cash flows while gradually rebuilding financial flexibility.

CEO
Christophe Beck
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2003-06-09 | Forward | 2:1 |
| 1998-01-16 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 902
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:25.33M
Value:$6.48B
BLACKROCK, INC.
Shares:22.81M
Value:$5.84B
BLACKROCK INC.
Shares:21.75M
Value:$5.57B
Summary
Showing Top 3 of 2,297

